{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:47:55Z","timestamp":1755218875968,"version":"3.43.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Introduction and importance:<\/jats:title>\n            <jats:p>The use of cyclophosphamide in women of childbearing age with severe systemic lupus erythematosus is normally indicated. However, cyclophosphamide is generally avoided during pregnancy due to the risk of teratogenicity, especially since its effect on fetal survival is poorly understood. This is a case report of a lupus patient exposed to cyclophosphamide during pregnancy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case presentation:<\/jats:title>\n            <jats:p>A 35-year-old woman with a history of lupus presented to our outpatient clinic in the 12th week of pregnancy for her sixth routine cyclophosphamide bolus. The fetal echocardiogram result with the gynecology consultation was normal with the recommendation for a medical termination of pregnancy, which has been refused by the patient. Shared decision-making with the patient included a discussion of the maternal risks of continuation of pregnancy in the setting of worsening systemic function and the fetal risks of definitive treatment with cyclophosphamide for a lupus flare and the patient decided to proceed with the pregnancy. Treatment with immunosuppressants, including azathioprine was initiated replacing cyclophosphamide with close monitoring of her and the fetus every month.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Clinical discussion:<\/jats:title>\n            <jats:p>The first trimester of pregnancy seems to be particularly susceptible to fetal malformations, although CPA effects on fetuses in later stages of pregnancy are also reported occasionally. Nonetheless, its repercussions on fetal survival remain poorly comprehended.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>In conclusion, exposing pregnancy to cyclophosphamide could end with pregnancy loss. Based on our experience, the survival of the fetus is strongly in doubt when cyclophosphamide is required to treat lupus in the mother. However, in rare cases, it could be without complications.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ms9.0000000000001641","type":"journal-article","created":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T02:00:46Z","timestamp":1704247246000},"page":"1156-1160","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Successful pregnancy after cyclophosphamide therapy for systemic lupus erythematosus: a case report"],"prefix":"10.1097","volume":"86","author":[{"given":"Tasneem","family":"Drie","sequence":"first","affiliation":[{"name":"Rheumatology Department, Faculty of Medicine, Damascus University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mhd Imadaldin","family":"Alsamman","sequence":"additional","affiliation":[{"name":"Surgery Department, Faculty of Medicine, Damascus University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raghad","family":"Tarcha","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Faculty of Medicine, Damascus University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghina","family":"Haidar","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Faculty of Medicine, Damascus University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maysoun","family":"Kudsi","sequence":"additional","affiliation":[{"name":"Damascus University, Syrian Arab Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,2]]},"reference":[{"key":"R1-20250806","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13244-022-01243-2","article-title":"Clinical and radiological features of lung disorders related to connective-tissue diseases: a pictorial essay","volume":"13","author":"Palmucci","year":"2022","journal-title":"Insights Imaging"},{"key":"R3-20250806","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1007\/s00204-019-02589-1","article-title":"Novel insights into the mechanism of cyclophosphamide-induced bladder toxicity: chloroacetaldehyde\u2019s contribution to urothelial dysfunction in vitro","volume":"93","author":"Mills","year":"2019","journal-title":"Arch toxicol"},{"key":"R4-20250806","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.790962","article-title":"Immunotherapy for refractory autoimmune encephalitis","volume":"12","author":"Yang","year":"2021","journal-title":"Front Immunol"},{"key":"R5-20250806","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1177\/09612033211021163","article-title":"Pregnancy in patients with systemic lupus erythematosus after cyclophosphamide therapy","volume":"30","author":"Sen","year":"2021","journal-title":"Lupus"},{"key":"R6-20250806","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3390\/jcm7120552","article-title":"Fetal toxicity of immunosuppressive drugs in pregnancy","volume":"7","author":"Ponticelli","year":"2018","journal-title":"J Clin Med"},{"key":"R7-20250806","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s13075-020-02292-y","article-title":"Ovarian dysfunction with moderate-dose intravenous cyclophosphamide (modified nih regimen) and mycophenolate mofetil in young adults with severe lupus: a prospective cohort study","volume":"22","author":"Sharma","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"R8-20250806","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1007\/s10067-014-2686-z","article-title":"Fertility, ovarian failure, and pregnancy outcome in SLE patients treated with intravenous cyclophosphamide in Saudi Arabia","volume":"33","author":"Alarfaj","year":"2014","journal-title":"Clin Rheumatol"},{"key":"R9-20250806","doi-asserted-by":"crossref","first-page":"5325","DOI":"10.1038\/s41598-023-32538-z","article-title":"Acceptance and willingness-to-pay for oocyte cryopreservation in medical versus age-related fertility preservation scenarios among Swedish female university students","volume":"13","author":"Gambadauro","year":"2023","journal-title":"Sci Rep"},{"key":"R10-20250806","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1007\/s10067-020-05173-6","article-title":"Rheumatology-led pregnancy clinic: enhancing the care of women with rheumatic diseases during pregnancy","volume":"39","author":"El Miedany","year":"2020","journal-title":"Clin Rheumatol"},{"key":"R12-20250806","doi-asserted-by":"crossref","first-page":"97","DOI":"10.18773\/austprescr.2019.026","article-title":"Immunomodulatory drugs in pregnancy and lactation","volume":"42","author":"Paizis","year":"2019","journal-title":"Aust Prescr"},{"key":"R13-20250806","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1097\/JS9.0000000000000373","article-title":"The SCARE 2023 guideline: updating consensus surgical case report (scare) guidelines","volume":"109","author":"Sohrabi","year":"2023","journal-title":"Int J Surg Lond Engl"},{"key":"R14-20250806","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European League against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"71","author":"Arranger","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"R15-20250806","first-page":"1123","article-title":"Systemic lupus erythematosus: lupus nephritis","volume":"2015","author":"Madhok","year":"2015","journal-title":"BMJ Clin Evid"},{"key":"R16-20250806","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/npp.2014.147","article-title":"Developmental consequences of fetal exposure to drugs: what we know and what we still must learn","volume":"40","author":"Ross","year":"2015","journal-title":"Neuropsychopharmacol"},{"issue":"suppl 1","key":"R17-20250806","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00404-011-1859-0","article-title":"Successful pregnancy after cyclophosphamide therapy for lupus nephritis","volume":"283","author":"Lannes","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"R18-20250806","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/tcm.1770050202","article-title":"Cyclophosphamide teratogenesis: a review","volume":"5","author":"Makes","year":"1985","journal-title":"Teratog Carcinogen Mutagen"},{"key":"R19-20250806","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/jjco\/hyw073","article-title":"Anticancer drugs during pregnancy","volume":"46","author":"Miyamoto","year":"2016","journal-title":"Jpn J Clin Oncol"},{"key":"R20-20250806","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.3390\/cancers14133103","article-title":"Transplacental passage and fetal effects of antineoplastic treatment during pregnancy","volume":"14","author":"Triarico","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R21-20250806","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.3390\/cancers12123623","article-title":"Long-term neurodevelopmental outcome of children after in utero exposure to chemotherapy","volume":"12","author":"Korakiti","year":"2020","journal-title":"Cancers (Basel)"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000001641","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T13:14:25Z","timestamp":1754486065000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000001641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,3]]},"references-count":19,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000001641","relation":{},"ISSN":["2049-0801"],"issn-type":[{"type":"electronic","value":"2049-0801"}],"subject":[],"published":{"date-parts":[[2024,1,3]]},"assertion":[{"value":"2023-10-31","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}